4//SEC Filing
Alter Jeffrey D. 4
Accession 0000899243-22-023091
CIK 0001580063other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 4:30 PM ET
Size
7.6 KB
Accession
0000899243-22-023091
Insider Transaction Report
Form 4
Alter Jeffrey D.
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-06-15+148,810→ 148,810 totalExercise: $0.64Exp: 2032-06-15→ Common Stock (148,810 underlying) - Award
Common Stock
2022-06-15+96,154→ 163,672 total
Footnotes (2)
- [F1]Represents 96,154 restricted stock units, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
- [F2]This option represents the right to purchase 148,810 shares of the Issuer's common stock, which vest in full on the earlier of (1) June 15, 2023 or (2) the date of the Issuer's 2023 annual meeting of stockholders, subject to the Reporting Person's continued service to the Issuer.
Documents
Issuer
BIORA THERAPEUTICS, INC.
CIK 0001580063
Entity typeother
Related Parties
1- filerCIK 0001813868
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 4:30 PM ET
- Size
- 7.6 KB